Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium

As promising compounds to lower Lipoprotein(a) (Lp(a)) are emerging, the need for a precise characterization and comparability of the Lp(a)-associated cardiovascular risk is increasing. Therefore, we aimed to evaluate the distribution of Lp(a) concentrations across the European population, to charac...

Full description

Saved in:

Bibliographic Details
Published in:	European heart journal Vol. 38; no. 32; p. 2490
Main Authors:	Waldeyer, Christoph, Makarova, Nataliya, Zeller, Tanja, Schnabel, Renate B, Brunner, Fabian J, Jørgensen, Torben, Linneberg, Allan, Niiranen, Teemu, Salomaa, Veikko, Jousilahti, Pekka, Yarnell, John, Ferrario, Marco M, Veronesi, Giovanni, Brambilla, Paolo, Signorini, Stefano G, Iacoviello, Licia, Costanzo, Simona, Giampaoli, Simona, Palmieri, Luigi, Meisinger, Christa, Thorand, Barbara, Kee, Frank, Koenig, Wolfgang, Ojeda, Francisco, Kontto, Jukka, Landmesser, Ulf, Kuulasmaa, Kari, Blankenberg, Stefan
Format:	Journal Article
Language:	English
Published:	England 21.08.2017
Subjects:	Adult Biomarkers - metabolism Cardiovascular Diseases - etiology Cardiovascular Diseases - mortality Europe - epidemiology Female Humans Kaplan-Meier Estimate Lipoprotein(a) - metabolism Lipoprotein(a) - physiology Male Middle Aged Prognosis Prospective Studies Residence Characteristics - statistics & numerical data Risk Assessment BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) Lipoprotein(a) MORGAM (MONICA Risk Genetics Archiving and Monograph) Mortality Cardiovascular risk
ISSN:	1522-9645, 1522-9645
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!